SPOTLIGHT -
Making Sense of the Reintervention Rate for BPH
Letter: BPH guidelines may ignore FDA, insurance criteria
"As we seek to understand MIST retreatment rates, as Houlihan and Köhler suggest, we must rely upon real-world population data," writes Gregg Eure, MD, in a letter to the editor.
